Answers are grounded in this paper and cite their sources.
This study suggests nutrient-driven mTORC1 can blunt insulin signaling by reducing IRS-1 and PI3K activity. Evidence is experimental, not clinical.
No takes yet. Share an insight, caveat, or question.
Deborah Iodice (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: